Unleashing the Power of Tregs
Three Treg therapeutic modalities addressing neurodegenerative, autoimmune, and metabolic diseases
Enhancing regulatory T cells (Tregs) through multiple product modalities
We are a clinical-stage company focused on developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Keep up-to-date with the latest news about Coya Therapeutics.